Has Catherine le received payments from drug or device companies?

Yes. Drug and device makers reported $3,016 in general payments to Catherine le across 73 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Catherine le did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Catherine le come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Catherine le

Physician Assistant · Indianapolis, INNPI 1932144656

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 73 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 23.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,458, 5.2 times the $279 reported in 2022.

$3,016in general payments, 2019–2025

Across 73 payments — averaging $41.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$705
Johnson & Johnson$333
Gilead$293
Takeda Pharmaceuticals U.S.A., Inc.$272
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$262
Madrigal Pharmaceuticals$222
plus $930 from 13 others

What the payments were for

Food & beverage$3,016100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	19	$705
Johnson & Johnson	6	$333
Gilead	5	$293
Takeda Pharmaceuticals U.S.A., Inc.	10	$272
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	8	$262
Madrigal Pharmaceuticals	2	$222
Boston Scientific	2	$187
Neurocrine Biosciences, Inc.	1	$132
Regeneron	1	$124
Ardelyx, Inc.	4	$97
Sanofi	2	$81
Phathom Pharmaceuticals, Inc.	3	$60
Aimmune Therapeutics, Inc.	2	$54
Novo Nordisk	1	$42
Ferring Pharmaceuticals Inc.	2	$35
Pfizer	2	$35
Regeneron Healthcare Solutions, Inc.	1	$34
Merck	1	$28
Lilly USA, LLC	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,016 in reported general payments places this provider in the 85th percentile of 1,955 physician assistant providers in Indiana.

See all physician assistant providers in Indiana →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Pantoprazole Sodium	88	$1,098

Paid to pharmacies, not to this prescriber.

Other physician assistant in Indianapolis

Andrew NordIndianapolis$47K
Qun Ming ZhangIndianapolis$28K
Lindsay YoderIndianapolis$21K
Mackenzie LawsonIndianapolis$15K
Christina RaceIndianapolis$13K
Zara BogenschutzIndianapolis$12K
Ashley WorthingtonIndianapolis$11K
Madison MaloofIndianapolis$10K
Michaela WehrIndianapolis$10K
Ryan RosebroughIndianapolis$8K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →